Qixian Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qixian Feng has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Quanxi Wang
College of Animal Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China
2 shared publications Beilei Chen
Fujian Key Laboratory of Traditional Chinese Veterinary Medicine and Animal Health/University Key Laboratory for Integrated Chinese Traditional and Western Veterinary Medicine and Animal Healthcare in Fujian Province, College of Animal Science, Fujian Agriculture and Forestry University
1 shared publication- Jiancheng Chen
College of Animal Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China
1 shared publication Jiaqi Chen
College of Animal Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China
1 shared publicationJingru Xu
Fujian Key Laboratory of Traditional Chinese Veterinary Medicine and Animal Health/University Key Laboratory for Integrated Chinese Traditional and Western Veterinary Medicine and Animal Healthcare in Fujian Province, College of Animal Science, Fujian Agriculture and Forestry University
1 shared publicationKaizhao Zhang
Fujian Key Laboratory of Traditional Chinese Veterinary Medicine and Animal Health/University Key Laboratory for Integrated Chinese Traditional and Western Veterinary Medicine and Animal Healthcare in Fujian Province, College of Animal Science, Fujian Agriculture and Forestry University
1 shared publication
Latest Publications
- Open Access
- 22 September 2026
- Published by American Society for Microbiology in mSystems
- Vol. 11 (9)
Novel insights into Radix Pseudostellariae saponins assist Mycoplasma gallisepticum attenuated vaccine to enhance the immunoprotection of chicken
Mycoplasma gallisepticum (MG) is a major pathogen causing chronic respiratory disease in chickens, and the MG-attenuated vaccine (MGAV) often fails to induce effective mucosal immunity. Radix Pseudostellariae saponins (RPS), important bioactive components of the traditional Chinese herb, have been utilized for immunomodulation, although the underlying mechanisms remain to be elucidated. In this study, chickens were randomly assigned to groups receiving intranasal MGAV alone, MGAV plus RPS at different doses, or appropriate controls. Serum, tracheal mucosa, and respiratory lavage samples were collected for antibody measurement, cytokine profiling, histological assessment, and metagenomic/metabolomic analyses. RPS significantly increased MG-specific antibody levels and enhanced expression of the immunomodulatory cytokines, while suppressing that of pro-inflammatory factors. It also promoted tracheal mucosal integrity by elevating goblet cell numbers and mucosal epithelial height. Through metagenomic and metabolomic analysis, RPS was found to enrich the respiratory bacterium Lactobacillus sp. UMNPBX13, which was positively correlated with the metabolite phosphatidylcholine (PC). Intranasal administration of Lactobacillus increased mucin 2 ( MUC2 ) and PC levels in tracheal mucosa. Similarly, PC combined with MGAV enhanced mucosal immunity by modulating cytokines and increasing MG-specific antibodies. These findings demonstrate that RPS enhances MGAV-induced respiratory mucosal immunity and provides a novel adjuvant strategy for improving poultry respiratory disease vaccines by modulating the respiratory microbiota, specifically through enrichment of Lactobacillus sp. UMNPBX13, which promotes PC production. IMPORTANCE: Mycoplasma gallisepticum (MG) constitutes a notable challenge to poultry health. Although the MG-attenuated vaccine (MGAV) is widely used for disease control, it often fails to induce robust mucosal immunity. Here, we demonstrate that intranasal co-administration of Radix Pseudostellariae saponins (RPS) with MGAV augments mucosal immunoprotection. Integrated metagenomic and metabolomic analyses revealed that RPS enriches respiratory Lactobacillus , which in turn promotes the production of its key metabolite phosphatidylcholine (PC), thereby supporting mucosal immune enhancement. These findings offer a promising strategy for improving poultry vaccine efficacy and may provide a basis for future exploration of mucosal vaccination approaches in other animal species.
- 22 September 2026
- Published by American Society for Microbiology in mSystems
- Vol. 11 (9)
Open AccessNovel insights into Radix Pseudostellariae saponins assist Mycoplasma gallisepticum attenuated vaccine to enhance the immunoprotection of chicken
Mycoplasma gallisepticum (MG) is a major pathogen causing chronic respiratory disease in chickens, and the MG-attenuated vaccine (MGAV) often fails to induce effective mucosal immunity. Radix Pseudostellariae saponins (RPS), important bioactive components of the traditional Chinese herb, have been utilized for immunomodulation, although the underlying mechanisms remain to be elucidated. In this study, chickens were randomly assigned to groups receiving intranasal MGAV alone, MGAV plus RPS at different doses, or appropriate controls. Serum, tracheal mucosa, and respiratory lavage samples were collected for antibody measurement, cytokine profiling, histological assessment, and metagenomic/metabolomic analyses. RPS significantly increased MG-specific antibody levels and enhanced expression of the immunomodulatory cytokines, while suppressing that of pro-inflammatory factors. It also promoted tracheal mucosal integrity by elevating goblet cell numbers and mucosal epithelial height. Through metagenomic and metabolomic analysis, RPS was found to enrich the respiratory bacterium Lactobacillus sp. UMNPBX13, which was positively correlated with the metabolite phosphatidylcholine (PC). Intranasal administration of Lactobacillus increased mucin 2 ( MUC2 ) and PC levels in tracheal mucosa. Similarly, PC combined with MGAV enhanced mucosal immunity by modulating cytokines and increasing MG-specific antibodies. These findings demonstrate that RPS enhances MGAV-induced respiratory mucosal immunity and provides a novel adjuvant strategy for improving poultry respiratory disease vaccines by modulating the respiratory microbiota, specifically through enrichment of Lactobacillus sp. UMNPBX13, which promotes PC production. IMPORTANCE: Mycoplasma gallisepticum (MG) constitutes a notable challenge to poultry health. Although the MG-attenuated vaccine (MGAV) is widely used for disease control, it often fails to induce robust mucosal immunity. Here, we demonstrate that intranasal co-administration of Radix Pseudostellariae saponins (RPS) with MGAV augments mucosal immunoprotection. Integrated metagenomic and metabolomic analyses revealed that RPS enriches respiratory Lactobacillus , which in turn promotes the production of its key metabolite phosphatidylcholine (PC), thereby supporting mucosal immune enhancement. These findings offer a promising strategy for improving poultry vaccine efficacy and may provide a basis for future exploration of mucosal vaccination approaches in other animal species.
- Open Access
- 1 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1)
Innate Immune Evasion of Porcine Epidemic Diarrhea Virus Through miRNA‐193a‐5p/IL22/pBD1 Pathway in Intestinal Epithelium
Porcine epidemic diarrhea (PED) virus (PEDV) is a highly contagious intestinal infection that primarily affects suckling pigs. The interaction about the innate immune evasion of PEDV in intestinal epithelium and microRNA (miRNA) remains unclear. A strain of PEDV belonging to the G2a genotype, designated FJND 2022, was successfully isolated and confirmed. Then, the miRNA profile in exosomes‐derived from intestinal porcine epithelial cell line (IPEC) infected with PEDV FJND 2022 for 48 h was evaluated. In exosomes from PEDV‐infected IPECs, 34 miRNAs showed differential expression relative to blank cells. A total of 7762 target genes of those differentially expressed miRNAs were forecast, and the miR‐193a‐5P and its target mRNA interleukin (IL)22 and porcine β‐defensin 1 (pBD1) attracted our interest. After infection with PEDV for 48 h, the mRNA levels and protein levels of IL22 and pBD1 were both notably downregulated, while the mRNA level of miR‐193a‐5P was significantly decreased. When IPECs were pretreated with the mimic of miR‐193a‐5P and then infected with PEDV, the mRNA levels of IL22 and pBD1 were significantly increased while the viral load of PEDV was significantly reduced. However, siRNA‐mediated knockdown of IL22 abrogated the capacity of miR‐193a‐5p mimic pretreatment to restore pBD1 expression. Furthermore, the inhibitor of miR‐193a‐5P was pretreated with IPECs infected with PEDV, resulting in a notable downregulation of IL22 and pBD1 expression, and a significant upregulation of the virus load of PEDV. Finally, we also found that the expression levels of IL22, pBD1, and miR‐193a‐5P were notably reduced in the small intestinal epithelium of suckling piglets infected with PEDV for 48 h. Therefore, in this study we reveal that PEDV downregulates the miR‐193a‐5P expression in the intestinal epithelium to evade the antivirus of IL22/pBD1, which provides new insights into PEDV molecular pathogenesis and immune evasion mechanisms.
- 1 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1)
Open AccessInnate Immune Evasion of Porcine Epidemic Diarrhea Virus Through miRNA‐193a‐5p/IL22/pBD1 Pathway in Intestinal Epithelium
Porcine epidemic diarrhea (PED) virus (PEDV) is a highly contagious intestinal infection that primarily affects suckling pigs. The interaction about the innate immune evasion of PEDV in intestinal epithelium and microRNA (miRNA) remains unclear. A strain of PEDV belonging to the G2a genotype, designated FJND 2022, was successfully isolated and confirmed. Then, the miRNA profile in exosomes‐derived from intestinal porcine epithelial cell line (IPEC) infected with PEDV FJND 2022 for 48 h was evaluated. In exosomes from PEDV‐infected IPECs, 34 miRNAs showed differential expression relative to blank cells. A total of 7762 target genes of those differentially expressed miRNAs were forecast, and the miR‐193a‐5P and its target mRNA interleukin (IL)22 and porcine β‐defensin 1 (pBD1) attracted our interest. After infection with PEDV for 48 h, the mRNA levels and protein levels of IL22 and pBD1 were both notably downregulated, while the mRNA level of miR‐193a‐5P was significantly decreased. When IPECs were pretreated with the mimic of miR‐193a‐5P and then infected with PEDV, the mRNA levels of IL22 and pBD1 were significantly increased while the viral load of PEDV was significantly reduced. However, siRNA‐mediated knockdown of IL22 abrogated the capacity of miR‐193a‐5p mimic pretreatment to restore pBD1 expression. Furthermore, the inhibitor of miR‐193a‐5P was pretreated with IPECs infected with PEDV, resulting in a notable downregulation of IL22 and pBD1 expression, and a significant upregulation of the virus load of PEDV. Finally, we also found that the expression levels of IL22, pBD1, and miR‐193a‐5P were notably reduced in the small intestinal epithelium of suckling piglets infected with PEDV for 48 h. Therefore, in this study we reveal that PEDV downregulates the miR‐193a‐5P expression in the intestinal epithelium to evade the antivirus of IL22/pBD1, which provides new insights into PEDV molecular pathogenesis and immune evasion mechanisms.